20
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Reproducibility and Interobserver Agreement of Different Thyroid Imaging and Reporting Data Systems (TIRADS)

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Introduction: A number of classification systems (TIRADS) have been developed to estimate the likelihood of malignancy in thyroid nodules, but their reproducibility is yet to be assessed. We evaluated the interobserver variability and diagnostic performance of the TIRADS in Kwak’s modification (Kw-TIRADS) and European TIRADS (EU-TIRADS). Methods: Two independent specialists, blinded concerning the morphology of the nodules, evaluated ultrasound images of 153 thyroid nodules identified in 149 patients at multiple time points. Results: The interobserver agreement (Cohen’s κ) was 0.52 and 0.67 for Kw-TIRADS and EU-TIRADS, respectively, and rated as substantial. There were strong correlations between Kw-TIRADS and EU-TIRADS for the two observers with Spearman’s coefficients of 0.731 ( p = 0.00025) and 0.661 ( p = 0.0012), respectively. Sensitivity of Kw-TIRADS for the diagnosis of thyroid cancer was 95–92.31% and that of EU-TIRADS was 92.31–89.74%, with specificity of about 60% for both TIRADS. Conclusion: Despite the wide variability in the description of single ultrasonographic features, both Kw-TIRADS and EU-TIRADS may be a useful diagnostic tool in clinical practice.

          Related collections

          Author and article information

          Journal
          ETJ
          ETJ
          10.1159/issn.2235-0640
          European Thyroid Journal
          S. Karger AG
          2235-0640
          2235-0802
          2021
          April 2021
          17 September 2020
          : 10
          : 2
          : 161-167
          Affiliations
          [_a] aDepartment of Endocrinology 1 at I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), Moscow, Russian Federation
          [_b] bLaboratory of Ultrasound Diagnostics, Federal State Research Institution “B.V. Petrovsky National Research Centre of Surgery”, Moscow, Russian Federation
          Author notes
          *Yulia P. Sych, Department of Endocrinology 1, I.M. Sechenov First Moscow State Medical, University of the Ministry of Health of the Russian Federation (Sechenov University), Trubetskaya ul., 8, bld.2., Moscow 119991 (Russian Federation), juliasytch@mail.ru
          Author information
          https://orcid.org/0000-0002-7000-0095
          https://orcid.org/0000-0002-3026-6315
          https://orcid.org/0000-0003-4503-950X
          https://orcid.org/0000-0002-1282-2576
          Article
          508959 Eur Thyroid J 2021;10:161–167
          10.1159/000508959
          8077651
          33981620
          baf15046-043d-4a30-9501-dc964990611b
          © 2020 The Author(s) Published by S. Karger AG, Basel

          This article is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND). Usage and distribution for commercial purposes as well as any distribution of modified material requires written permission. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

          History
          : 05 February 2020
          : 21 May 2020
          Page count
          Figures: 1, Tables: 4, Pages: 7
          Categories
          Clinical Thyroidology / Research Article

          Endocrinology & Diabetes,Neurology,Nutrition & Dietetics,Sexual medicine,Internal medicine,Pharmacology & Pharmaceutical medicine
          Interobserver variability,Thyroid nodules,Thyroid imaging

          Comments

          Comment on this article